Search results
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
Bennington Banner· 9 hours agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track...
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
WKRN Nashville· 9 hours agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), ...
As An ER Doctor, I Knew To Expect The Unexpected. Then My Neighbors Began Arriving At The Hospital.
HuffPost via Yahoo News· 23 minutes agoI could still picture the open board, paper money and game tokens on the living room carpet. Back in...
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
Benzinga· 9 hours agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 SN, a new drug ...
Could better inhalers help patients, and the planet?
The Sacramento Bee· 5 hours agoMiguel Divo, a lung specialist at Brigham and Women's Hospital in Boston, sits in an exam room across from Joel Rubinstein, who has asthma. Rubinstein, a retired psychiatrist ...
Recce Pharmaceuticals makes breakthrough in lung infection treatment with nebulised RECCE® 327
Proactive Investors· 24 hours agoRecce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has received promising results from a pilot study...
VIDEO: Estes Park Health offers low dose lung CT scans
Estes Park Trail Gazette· 1 day agoEstes Park resident Jän Rigby is getting ready for a quick, painless test at Estes Park Health that...
Lung Cancer Action week: Lung cancer leads cancer deaths in New York
News 12· 1 day agoLung cancer is the leading cause of cancer deaths in New York, according to the Department of Health. The Gov. Mario Cuomo Bridge was illuminated in turquoise on Wednesday ...
Earnings call: MannKind reports robust Q1 growth, focuses on rare lung diseases
Investing.com· 1 day agoThe company's revenue growth has soared by over 250% in the past eight quarters, and it is well on...
Exacerbations Predict Poor Outcomes in NSCLC With IIP
Medscape· 1 day agoTreatment regimens for non–small cell lung cancer were independent predictors of...
